Insulet Corporation is a medical device company established in 2000 and headquartered in Acton, Massachusetts. The company specializes in the development, manufacturing, and marketing of insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the Omnipod System, comprises a small, disposable, tubeless insulin infusion device that adheres to the skin and a wireless personal diabetes manager, which can be operated via smartphone to facilitate dosage control. The Omnipod System offers a pain-free automated cannula insertion and is designed to enhance the diabetes management experience for users. Insulet distributes its products primarily through independent distributors, pharmacy channels, and direct sales in the United States, Canada, Europe, and the Middle East. Since receiving FDA approval in 2005, the Omnipod System has been adopted by approximately 425,000 users worldwide, reflecting Insulet's commitment to improving the lives of those managing diabetes.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Glooko
Series C in 2017
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Neighborhood Diabetes
Acquisition in 2011
Neighborhood Diabetes, Inc. is a prominent distributor of durable medical equipment focused on serving individuals with diabetes. The company specializes in direct-to-consumer sales of essential diabetes supplies, including glucose testing equipment, insulin pumps, and various related consumables. In addition to these products, Neighborhood Diabetes offers support services to assist patients in managing their condition effectively. By providing a comprehensive range of diabetes-related products and services, the company aims to enhance the quality of life for those living with Type 1 and Type 2 diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.